Variant report

Variant	nsv819045
Chromosome Location	chr14:36985729-36987493
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:15)
CpG islands
(count:428)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:15 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr14:36986448-36986648	H1-hESC	embryonic stem cell:	n/a	n/a
2	CHD1	chr14:36986475-36986486	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTBP2	chr14:36987100-36990550	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTBP2	chr14:36985797-36986843	H1-hESC	embryonic stem cell:	n/a	n/a
5	GABPA	chr14:36986364-36986843	H1-hESC	embryonic stem cell:	n/a	n/a
6	POLR2A	chr14:36986988-36987237	H1-neurons	neurons:	n/a	n/a
7	RAD21	chr14:36986551-36986576	H1-hESC	embryonic stem cell:	n/a	n/a
8	SUZ12	chr14:36981170-36992861	NT2-D1	testis:	n/a	n/a
9	SUZ12	chr14:36985791-36990585	H1-hESC	embryonic stem cell:	n/a	n/a
10	TBP	chr14:36986482-36986672	H1-hESC	embryonic stem cell:	n/a	n/a
11	TBP	chr14:36987067-36987212	H1-hESC	embryonic stem cell:	n/a	n/a
12	TBP	chr14:36987457-36987567	H1-hESC	embryonic stem cell:	n/a	n/a
13	TCF12	chr14:36985936-36986223	H1-hESC	embryonic stem cell:	n/a	n/a
14	TCF12	chr14:36986327-36986521	H1-hESC	embryonic stem cell:	n/a	n/a
15	YY1	chr14:36986388-36986807	H1-hESC	embryonic stem cell:	n/a	n/a

(count:428 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr14:36985711-36985761	MCF10A-Er-Src	breast:	n/a
2	chr14:36985711-36985761	MCF10A-Er-Src	breast:	n/a
3	chr14:36986996-36987046	HCT-116	colon:	n/a
4	chr14:36986585-36986635	GM06990	blood:	n/a
5	chr14:36985711-36985761	NHBE	bronchial:	n/a
6	chr14:36986585-36986635	GM19239	blood:	n/a
7	chr14:36986363-36986413	HMEC	breast:	n/a
8	chr14:36986585-36986635	SK-N-SH_RA	brain:	n/a
9	chr14:36987301-36987351	HepG2	liver:	n/a
10	chr14:36985711-36985761	K562	blood:	n/a
11	chr14:36986363-36986413	AG09309	skin:	n/a
12	chr14:36987301-36987351	GM12878	blood:	n/a
13	chr14:36985905-36985955	HIPEpiC	eye:	n/a
14	chr14:36987301-36987351	BJ	skin:	n/a
15	chr14:36985905-36985955	ECC-1	luminal epithelium:	n/a
16	chr14:36987301-36987351	AG04449	skin:	fetal
17	chr14:36985711-36985761	SK-N-SH	brain:	n/a
18	chr14:36986585-36986635	Hepatocyte	liver:	n/a
19	chr14:36985711-36985761	PFSK-1	brain:	n/a
20	chr14:36985905-36985955	AoSMC	blood vessel:	n/a
21	chr14:36986585-36986635	HCPEpiC	choroid plexus:	n/a
22	chr14:36987301-36987351	GM19239	blood:	n/a
23	chr14:36985905-36985955	NHBE	bronchial:	n/a
24	chr14:36986363-36986413	T-47D	breast:	n/a
25	chr14:36986585-36986635	MCF-7	breast:	n/a
26	chr14:36986585-36986635	K562	blood:	n/a
27	chr14:36986585-36986635	GM12891	blood:	n/a
28	chr14:36987408-36987458	GM12878	blood:	n/a
29	chr14:36986585-36986635	HEK293	kidney:	embryo
30	chr14:36986996-36987046	PFSK-1	brain:	n/a
31	chr14:36987408-36987458	AG04449	skin:	fetal
32	chr14:36986363-36986413	GM06990	blood:	n/a
33	chr14:36986996-36987046	HPAEpiC	pulmonary alveolar:	n/a
34	chr14:36986996-36987046	HAEpiC	amniotic membrane:	n/a
35	chr14:36986363-36986413	SAEC	small airway:	n/a
36	chr14:36985905-36985955	HRE	kidney:	n/a
37	chr14:36986996-36987046	BJ	skin:	n/a
38	chr14:36985711-36985761	ECC-1	luminal epithelium:	n/a
39	chr14:36986363-36986413	NB4	blood:	n/a
40	chr14:36985711-36985761	HCM	heart:	n/a
41	chr14:36986363-36986413	BE2_C	brain:	n/a
42	chr14:36986996-36987046	RPTEC	kidney:	n/a
43	chr14:36987301-36987351	SK-N-SH_RA	brain:	n/a
44	chr14:36986363-36986413	NHDF-neo	bronchial:	n/a
45	chr14:36986996-36987046	SKMC	muscle:	n/a
46	chr14:36985711-36985761	HAEpiC	amniotic membrane:	n/a
47	chr14:36986585-36986635	PrEC	prostate:	n/a
48	chr14:36987301-36987351	Caco-2	colon:	n/a
49	chr14:36986585-36986635	PANC-1	pancreas:	n/a
50	chr14:36986585-36986635	Jurkat	blood:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr14:36986593..36988111-chr14:36992508..36994903,2	MCF-7	breast:

No data

Variant related genes	Relation type
SFTA3	TF binding region
NKX2-1-AS1	TF binding region
SFTA3	CpG island
NKX2-1-AS1	CpG island

Extended variants
information (count: 79 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:79 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs554832614	chr14:36985746-36985747	Bivalent/Poised TSS Active TSS Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
2	rs11541293	chr14:36985841-36985842	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs553403824	chr14:36985874-36985875	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs375480449	chr14:36985891-36985892	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs534281105	chr14:36985902-36985903	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs386776477	chr14:36985903-36985904	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs566916288	chr14:36985904-36985905	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs570771635	chr14:36985926-36985927	Bivalent Enhancer Bivalent/Poised TSS Active TSS Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
9	rs11541294	chr14:36986006-36986007	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs112799458	chr14:36986022-36986023	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs5807883	chr14:36986023-36986024	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs56670738	chr14:36986037-36986038	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs79849967	chr14:36986047-36986048	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs574552862	chr14:36986091-36986092	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
15	rs543274140	chr14:36986105-36986106	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs144177561	chr14:36986109-36986110	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs576538982	chr14:36986172-36986173	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs140427692	chr14:36986190-36986191	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs398118058	chr14:36986194-36986195	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs71124756	chr14:36986265-36986266	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs545347436	chr14:36986272-36986273	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs10139625	chr14:36986273-36986274	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs572546897	chr14:36986274-36986275	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs542496269	chr14:36986283-36986284	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs562274315	chr14:36986285-36986286	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs531107509	chr14:36986290-36986291	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs141117763	chr14:36986296-36986297	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs200610971	chr14:36986298-36986299	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs200871832	chr14:36986299-36986300	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs550912157	chr14:36986304-36986305	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs77021012	chr14:36986306-36986307	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs76977831	chr14:36986307-36986308	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs377039468	chr14:36986333-36986334	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs564521320	chr14:36986340-36986341	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs533460253	chr14:36986341-36986342	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs12896888	chr14:36986388-36986389	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
37	rs374569055	chr14:36986437-36986438	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs12896924	chr14:36986451-36986452	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs201995699	chr14:36986473-36986474	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs143269839	chr14:36986492-36986493	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs566854717	chr14:36986528-36986529	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs371404638	chr14:36986534-36986535	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs548436641	chr14:36986541-36986542	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs568279403	chr14:36986573-36986574	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
45	rs537209983	chr14:36986583-36986584	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs556880296	chr14:36986595-36986596	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
47	rs147542347	chr14:36986596-36986597	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
48	rs377417768	chr14:36986627-36986628	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
49	rs200560568	chr14:36986635-36986636	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
50	rs552685896	chr14:36986652-36986653	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Colorectal cancer	16774939	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	17899364	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Chronic myeloid leukemia	20724749	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Wilms tumour	21544195	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Burkitt''s lymphoma	19759907	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21785460	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Lung cancer	17925434	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
abnormal development	18461090	CNVD
Prostate cancer	21298110	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	21858162	CNVD
Lung cancer	20031968	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21183584	CNVD
Prostate cancer	21147910	CNVD

Chromatin state (count:71 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:36981400-36991200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
2	chr14:36983200-36986200	Bivalent/Poised TSS	Fetal Lung	lung
3	chr14:36984200-36986400	Weak transcription	Pancreas	Pancrea
4	chr14:36985400-36988200	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
5	chr14:36985600-36986400	Active TSS	Lung	lung
6	chr14:36985800-36986000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
7	chr14:36985800-36986400	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
8	chr14:36986000-36986200	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
9	chr14:36986200-36987000	Bivalent/Poised TSS	Brain Germinal Matrix	brain
10	chr14:36986400-36986600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
11	chr14:36986400-36986600	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
12	chr14:36986400-36986600	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr14:36986400-36986600	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
14	chr14:36986400-36986600	Bivalent Enhancer	Fetal Intestine Large	intestine
15	chr14:36986400-36986600	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
16	chr14:36986400-36986600	Flanking Bivalent TSS/Enh	Skeletal Muscle Female	skeletal muscle
17	chr14:36986400-36986600	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
18	chr14:36986400-36986600	Bivalent Enhancer	HMEC	breast
19	chr14:36986400-36986800	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
20	chr14:36986400-36986800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
21	chr14:36986400-36986800	Bivalent Enhancer	Brain Inferior Temporal Lobe	brain
22	chr14:36986400-36986800	Bivalent Enhancer	Left Ventricle	heart
23	chr14:36986400-36986800	Transcr. at gene 5' and 3'	Lung	lung
24	chr14:36986400-36986800	Flanking Bivalent TSS/Enh	Right Ventricle	heart
25	chr14:36986400-36987000	Flanking Bivalent TSS/Enh	Psoas Muscle	Psoas
26	chr14:36986400-36987000	Bivalent/Poised TSS	Right Atrium	heart
27	chr14:36986400-36987200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
28	chr14:36986400-36987200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
29	chr14:36986400-36987600	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
30	chr14:36986400-36988200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
31	chr14:36986400-36988200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr14:36986400-36988200	Bivalent Enhancer	Esophagus	oesophagus
33	chr14:36986400-36988400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
34	chr14:36986400-36988600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
35	chr14:36986400-36989000	Bivalent Enhancer	Liver	Liver
36	chr14:36986400-36989200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr14:36986400-36989800	Enhancers	Gastric	stomach
38	chr14:36986400-36989800	Enhancers	Pancreas	Pancrea
39	chr14:36986600-36986800	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
40	chr14:36986600-36986800	Bivalent Enhancer	Sigmoid Colon	Sigmoid Colon
41	chr14:36986600-36987000	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
42	chr14:36986600-36987000	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
43	chr14:36986600-36987000	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
44	chr14:36986600-36987200	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
45	chr14:36986600-36987200	Bivalent Enhancer	Stomach Smooth Muscle	stomach
46	chr14:36986600-36987400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr14:36986600-36988200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
48	chr14:36986600-36988200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
49	chr14:36986600-36989400	Bivalent Enhancer	Spleen	Spleen
50	chr14:36986800-36987000	Flanking Bivalent TSS/Enh	Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links